Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RHO family interacting cell polarization regulator 2 (RIPOR2) is an adaptor and inhibitor protein that directly binds RHOA GTPase and suppresses its activity, thus playing a key role in cell migration, polarization, and cytoskeletal organization[1][3]. It is essential for several biological processes: it regulates T cell and neutrophil migration and polarization via RHOA inhibition, acts as a negative regulator of cell proliferation, and influences skeletal muscle cell differentiation and myoblast fusion[1][3]. In the auditory system, RIPOR2 is necessary for the development and maintenance of hair cell stereocilia; its loss causes non-syndromic hereditary deafness due to defects in hair cell bundle structure[3][4]. RIPOR2 activity is tightly regulated by upstream kinases and it integrates signals for immune cell migration, myogenesis, and autophagy in a context-dependent manner[1][3]. No direct therapeutic agents targeting RIPOR2 are currently known; however, its genetic variants serve as biomarkers in the diagnosis of hereditary deafness syndromes[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RHO family interacting cell polarization regulator 2 (RIPOR2).